ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Anti-atherosclerotic effects of geraniin through the gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway in mice

Lin, Kaiyang; Wang, Xuedong; Li, Ji; Zhao, Peng; Xi, Xiangwen; Feng, Yi; Yin, Li; Tian, Jinwei; Li, Hulun; Liu, Xinxin*; Yu, Bo哈尔滨医科大学
PHYTOMEDICINE2022-7DOI: 10.1016/j.phymed.2022.154104
12被引6阅读
引用收藏
分享

摘要

Background: Cardiovascular disease is a leading cause of death, which signifies the urgent need for effective antiatherosclerotic strategies. Gut microbiota-dependent trimethylamine-N-oxide (TMAO) is associated with atherosclerosis, and geraniin, a natural polyphenol with various biological activities, might play key role in this process. @@@ Purpose: We aimed to investigate the pharmacological activity of geraniin in atherosclerosis through remodeling the gut microbiota. @@@ Methods: C57BL/6J ApoE(-/-) mice were administrated geraniin for 12 weeks. The colon contents were analyzed via 16S rRNA sequencing. Pathological staining was performed to evaluate the atherosclerotic characteristics. Cytokine assays detected the levels of plasma inflammatory cytokines. RAW264.7 cells were cultured in vitro and treated with TMAO. Tandem Mass Tag quantitative proteomics analysis and western blot were performed to investigate the effect of TMAO in macrophages. @@@ Results: The plasma TMAO level in mice significantly decreased after geraniin intervention. The predominant intestinal microflora from geraniin-treated mice were Bacteroides (65.3%) and Firmicutes (30.6%). Pathological staining demonstrated that administration of geraniin attenuated atherosclerotic characteristics. After geraniin treatment, plasma levels of IL-1 beta, IL-6, and TNF-alpha in mice were significantly reduced, and IL-10 levels were significantly increased. Proteomics analysis demonstrated the number of differentially expressed proteins after TMAO administration. In vitro study suggested that the atherogenic effect of TMAO could be attributed to changes in CD36, transmembrane protein 106a, apolipoprotein C1, macrophage scavenger receptor types I and II, and alpha-2-macroglobulin. @@@ Conclusion: Geraniin might be an effective prospective drug against cardiovascular diseases, and the gut microbiota is a potential target to reduce the risk of atherosclerotic disease.

学科与关键词

关键词
Gut microbiotaGeraniinTrimethylamine-N-oxideAtherosclerosisMacrophages
相关
加载中…
  • Gut-Flora-Dependent Metabolite Trimethylamine-N-Oxide Promotes Atherosclerosis-Associated Inflammation Responses by Indirect ROS Stimulation and Signaling Involving AMPK and SIRT1
    Zhou, Sa; Xue, Jiamin; Shan, Jingbo; Hong, Yingxiang; Zhu, Wenkang; Nie, Zhiyan; Zhang, Yujie; Ji, Nanxi; Luo, Xuegang; Zhang, Tongcun; Ma, Wenjian*OncoImmunology, 2022, 14(16): 3338.被引 13
  • Therapeutic potential of traditional Chinese medicine against atherosclerosis: Targeting trimethylamine N-oxide
    Zhou, Peng; Kang, Jun-li; Cheng, Qi-qing; Chen, Ming-tai; Xie, Ying; Zhou, Hua*PHYTOMEDICINE, 2022, 104: 154305.被引 1
  • Curcumin attenuates cadmium-induced atherosclerosis by regulating trimethylamine-N-oxide synthesis and macrophage polarization through remodeling the gut microbiota
    Zhang, Jiexin; Ou, Caiwen*; Chen, Minsheng*Ecotoxicology and Environmental Safety, 2022, 244: 114057.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-07
卷期
第 101 卷
页码
154104
DOI
10.1016/j.phymed.2022.154104
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
High-level Hospital Foster Grants from Fujian Provincial Hospital, Fujian province, China [2020HSJJ05]; Fujian Provincial Health Technology Project [2019-ZQN-10]; National Key R&D Program of China [2016YFC1301101]; National Natural Science Foundation of China [82000330]; Fund of Key Laboratory of Myocardial Ischemia, Ministry of Education [KF202011]

作者

  • L

    Lin, Kaiyang (第一作者)

    fujian med univ · fujian prov hosp

  • W

    Wang, Xuedong

    2 · harbin med univ

查看全部 11 位作者收起作者
  • L

    Li, Ji

    2 · harbin med univ

  • Z

    Zhao, Peng

    2 · harbin med univ

  • X

    Xi, Xiangwen

    2 · harbin med univ

  • F

    Feng, Yi

    2 · harbin med univ

  • Y

    Yin, Li

    2 · harbin med univ

  • T

    Tian, Jinwei

    2 · harbin med univ · guilin med univ

  • L

    Li, Hulun

    harbin med univ

  • L

    Liu, Xinxin (通讯)

    2 · harbin med univ

  • Y

    Yu, Bo

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417